Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

A unique insight into the MiRNA profile during genital chlamydial infection.

Benyeogor I, Simoneaux T, Wu Y, Lundy S, George Z, Ryans K, McKeithen D, Pais R, Ellerson D, Lorenz WW, Omosun T, Thompson W, Eko FO, Black CM, Blas-Machado U, Igietseme JU, He Q, Omosun Y.

BMC Genomics. 2019 Feb 18;20(1):143. doi: 10.1186/s12864-019-5495-6.

2.

The molecular mechanism of induction of unfolded protein response by Chlamydia.

George Z, Omosun Y, Azenabor AA, Goldstein J, Partin J, Joseph K, Ellerson D, He Q, Eko F, McDonald MA, Reed M, Svoboda P, Stuchlik O, Pohl J, Lutter E, Bandea C, Black CM, Igietseme JU.

Biochem Biophys Res Commun. 2019 Jan 8;508(2):421-429. doi: 10.1016/j.bbrc.2018.11.034. Epub 2018 Nov 28.

PMID:
30503337
3.

Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Sahu R, Verma R, Dixit S, Igietseme JU, Black CM, Duncan S, Singh SR, Dennis VA.

Expert Rev Vaccines. 2018 Mar;17(3):217-227. doi: 10.1080/14760584.2018.1435279. Epub 2018 Feb 6. Review.

4.

The emerging role of ASC in dendritic cell metabolism during Chlamydia infection.

McKeithen DN, Omosun YO, Ryans K, Mu J, Xie Z, Simoneaux T, Blas-Machado U, Eko FO, Black CM, Igietseme JU, He Q.

PLoS One. 2017 Dec 7;12(12):e0188643. doi: 10.1371/journal.pone.0188643. eCollection 2017.

5.

Molecular Pathogenesis of Chlamydia Disease Complications: Epithelial-Mesenchymal Transition and Fibrosis.

Igietseme JU, Omosun Y, Nagy T, Stuchlik O, Reed MS, He Q, Partin J, Joseph K, Ellerson D, George Z, Goldstein J, Eko FO, Bandea C, Pohl J, Black CM.

Infect Immun. 2017 Dec 19;86(1). pii: e00585-17. doi: 10.1128/IAI.00585-17. Print 2018 Jan.

6.

Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice.

Pais R, Omosun Y, He Q, Blas-Machado U, Black C, Igietseme JU, Fujihashi K, Eko FO.

PLoS One. 2017 Jun 1;12(6):e0178537. doi: 10.1371/journal.pone.0178537. eCollection 2017.

7.

The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.

Ryans K, Omosun Y, McKeithen DN, Simoneaux T, Mills CC, Bowen N, Eko FO, Black CM, Igietseme JU, He Q.

BMC Immunol. 2017 May 19;18(1):27. doi: 10.1186/s12865-017-0212-1.

8.

The Roles of Unfolded Protein Response Pathways in Chlamydia Pathogenesis.

George Z, Omosun Y, Azenabor AA, Partin J, Joseph K, Ellerson D, He Q, Eko F, Bandea C, Svoboda P, Pohl J, Black CM, Igietseme JU.

J Infect Dis. 2017 Feb 1;215(3):456-465. doi: 10.1093/infdis/jiw569.

9.

Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis.

Igietseme JU, Omosun Y, Stuchlik O, Reed MS, Partin J, He Q, Joseph K, Ellerson D, Bollweg B, George Z, Eko FO, Bandea C, Liu H, Yang G, Shieh WJ, Pohl J, Karem K, Black CM.

PLoS One. 2015 Dec 17;10(12):e0145198. doi: 10.1371/journal.pone.0145198. eCollection 2015.

10.

Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.

Liu S, Sun W, Chu J, Huang X, Wu Z, Yan M, Zhang Q, Zhao P, Igietseme JU, Black CM, He C, Li Y.

PLoS One. 2015 Apr 20;10(4):e0124992. doi: 10.1371/journal.pone.0124992. eCollection 2015.

11.

Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model.

Pan Q, Pais R, Ohandjo A, He C, He Q, Omosun Y, Igietseme JU, Eko FO.

Vaccine. 2015 Apr 8;33(15):1865-72. doi: 10.1016/j.vaccine.2015.02.007. Epub 2015 Feb 17. Erratum in: Vaccine. 2015 Jun 4;33(24):1849.

12.

Vibrio cholerae ghosts (VCG) exert immunomodulatory effect on dendritic cells for enhanced antigen presentation and induction of protective immunity.

Eko FO, Mania-Pramanik J, Pais R, Pan Q, Okenu DM, Johnson A, Ibegbu C, He C, He Q, Russell R, Black CM, Igietseme JU.

BMC Immunol. 2014 Dec 31;15:584. doi: 10.1186/s12865-014-0056-x.

13.

Reply to Shao et al.

Igietseme JU, Black CM.

J Infect Dis. 2013 Aug 15;208(4):709-10. doi: 10.1093/infdis/jit217. Epub 2013 May 9. No abstract available.

PMID:
23661795
14.

Development of PCR assays for detection of Trichomonas vaginalis in urine specimens.

Bandea CI, Joseph K, Secor EW, Jones LA, Igietseme JU, Sautter RL, Hammerschlag MR, Fajman NN, Girardet RG, Black CM.

J Clin Microbiol. 2013 Apr;51(4):1298-300. doi: 10.1128/JCM.03101-12. Epub 2013 Feb 6.

15.

Prevention of Chlamydia-induced infertility by inhibition of local caspase activity.

Igietseme JU, Omosun Y, Partin J, Goldstein J, He Q, Joseph K, Ellerson D, Ansari U, Eko FO, Bandea C, Zhong G, Black CM.

J Infect Dis. 2013 Apr;207(7):1095-104. doi: 10.1093/infdis/jit009. Epub 2013 Jan 9.

16.

Chlamydial infection in vitamin D receptor knockout mice is more intense and prolonged than in wild-type mice.

He Q, Ananaba GA, Patrickson J, Pitts S, Yi Y, Yan F, Eko FO, Lyn D, Black CM, Igietseme JU, Thierry-Palmer M.

J Steroid Biochem Mol Biol. 2013 May;135:7-14. doi: 10.1016/j.jsbmb.2012.11.002. Epub 2012 Nov 29.

17.

Chlamydia vaccines: recent developments and the role of adjuvants in future formulations.

Igietseme JU, Eko FO, Black CM.

Expert Rev Vaccines. 2011 Nov;10(11):1585-96. doi: 10.1586/erv.11.139. Review.

PMID:
22043957
18.

Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.

Eko FO, Okenu DN, Singh UP, He Q, Black C, Igietseme JU.

Vaccine. 2011 May 12;29(21):3802-10. doi: 10.1016/j.vaccine.2011.03.027. Epub 2011 Mar 21.

19.

Induction of immune memory by a multisubunit chlamydial vaccine.

Eko FO, Ekong E, He Q, Black CM, Igietseme JU.

Vaccine. 2011 Feb 4;29(7):1472-80. doi: 10.1016/j.vaccine.2010.12.024. Epub 2010 Dec 22. Erratum in: Vaccine. 2011 Apr 27;29(19):3623-4.

20.

Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene.

Ifere GO, Equan A, Gordon K, Nagappan P, Igietseme JU, Ananaba GA.

Cancer Epidemiol. 2010 Aug;34(4):461-71. doi: 10.1016/j.canep.2010.04.009. Epub 2010 May 12.

21.

Identification of candidate genes using the murine model of female genital tract infection with Chlamydia trachomatis.

Lyons JM, Igietseme JU, Black CM, Morré SA.

Drugs Today (Barc). 2009 Nov;45 Suppl B:51-9. Review.

PMID:
20011695
22.

Immunolocalization and challenge studies using a recombinant Vibrio cholerae ghost expressing Trypanosoma brucei Ca(2+) ATPase (TBCA2) antigen.

Ramey K, Eko FO, Thompson WE, Armah H, Igietseme JU, Stiles JK.

Am J Trop Med Hyg. 2009 Sep;81(3):407-15.

23.

Role of T lymphocytes in the pathogenesis of Chlamydia disease.

Igietseme JU, He Q, Joseph K, Eko FO, Lyn D, Ananaba G, Campbell A, Bandea C, Black CM.

J Infect Dis. 2009 Sep 15;200(6):926-34. doi: 10.1086/605411.

24.

Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse.

Black CM, Driebe EM, Howard LA, Fajman NN, Sawyer MK, Girardet RG, Sautter RL, Greenwald E, Beck-Sague CM, Unger ER, Igietseme JU, Hammerschlag MR.

Pediatr Infect Dis J. 2009 Jul;28(7):608-13. doi: 10.1097/INF.0b013e31819b592e.

PMID:
19451856
25.

Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.

Ifere GO, Barr E, Equan A, Gordon K, Singh UP, Chaudhary J, Igietseme JU, Ananaba GA.

Cancer Detect Prev. 2009;32(4):319-28. doi: 10.1016/j.cdp.2008.12.002. Epub 2009 Jan 30.

PMID:
19186008
26.

A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.

Ekong EE, Okenu DN, Mania-Pramanik J, He Q, Igietseme JU, Ananaba GA, Lyn D, Black C, Eko FO.

FEMS Immunol Med Microbiol. 2009 Mar;55(2):280-91. doi: 10.1111/j.1574-695X.2008.00493.x. Epub 2008 Nov 18.

27.

Involvement of LEK1 in dendritic cell regulation of T cell immunity against Chlamydia.

He Q, Eko FO, Lyn D, Ananaba GA, Bandea C, Martinez J, Joseph K, Kellar K, Black CM, Igietseme JU.

J Immunol. 2008 Sep 15;181(6):4037-42.

28.

CCL5 regulation of mucosal chlamydial immunity and infection.

Sakthivel SK, Singh UP, Singh S, Taub DD, Igietseme JU, Lillard JW Jr.

BMC Microbiol. 2008 Aug 13;8:136. doi: 10.1186/1471-2180-8-136.

29.

Immunological evidence supporting the use of extracts from Boehmeria jamaicensis Urb for treating the common cold and sinus infections.

Williams LA, Igietseme JU, Whittaker JA, Smikle MF, Bailey-Shaw YA, Barton EN.

West Indian Med J. 2007 Dec;56(6):487-90.

PMID:
18646490
30.

Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.

Ifere GO, He Q, Igietseme JU, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Eko FO.

J Microbiol Immunol Infect. 2007 Jun;40(3):188-200.

PMID:
17639158
31.

Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.

He Q, Martinez-Sobrido L, Eko FO, Palese P, Garcia-Sastre A, Lyn D, Okenu D, Bandea C, Ananaba GA, Black CM, Igietseme JU.

Immunology. 2007 Sep;122(1):28-37. Epub 2007 Apr 23. Erratum in: Immunology. 2007 Oct;122(2):302.

32.

Combination vaccines: design strategies and future trends.

Igietseme JU, Eko FO, He Q, Black CM.

Expert Rev Vaccines. 2006 Dec;5(6):739-45. No abstract available.

PMID:
17184210
33.

A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.

Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO.

FEMS Immunol Med Microbiol. 2007 Feb;49(1):46-55. Epub 2006 Nov 9.

34.

Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion.

Barr EL, Ouburg S, Igietseme JU, Morré SA, Okwandu E, Eko FO, Ifere G, Belay T, He Q, Lyn D, Nwankwo G, Lillard JW Jr, Black CM, Ananaba GA.

J Microbiol Immunol Infect. 2005 Aug;38(4):244-54.

PMID:
16118671
35.

Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for activating Th1 response.

He Q, Moore TT, Eko FO, Lyn D, Ananaba GA, Martin A, Singh S, James L, Stiles J, Black CM, Igietseme JU.

J Immunol. 2005 Apr 15;174(8):4860-9.

36.

Chlamydia update.

Igietseme JU, Ward ME.

Expert Rev Vaccines. 2004 Dec;3(6):639-42. No abstract available.

PMID:
15606347
37.

A novel recombinant multisubunit vaccine against Chlamydia.

Eko FO, He Q, Brown T, McMillan L, Ifere GO, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Igietseme JU.

J Immunol. 2004 Sep 1;173(5):3375-82.

38.

Developing effective delivery systems for Chlamydia vaccines.

Igietseme JU, Eko FO, He Q, Bandea C, Black CM.

Curr Opin Mol Ther. 2004 Apr;6(2):182-94.

PMID:
15195931
39.

Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.

Igietseme JU, Eko FO, He Q, Black CM.

Expert Rev Vaccines. 2004 Feb;3(1):23-34. Review.

PMID:
14761241
40.

Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.

Eko FO, Schukovskaya T, Lotzmanova EY, Firstova VV, Emalyanova NV, Klueva SN, Kravtzov AL, Livanova LF, Kutyrev VV, Igietseme JU, Lubitz W.

Vaccine. 2003 Sep 8;21(25-26):3663-74.

PMID:
12922096
41.

Contemporary approaches to designing and evaluating vaccines against Chlamydia.

Igietseme JU, Eko FO, Black CM.

Expert Rev Vaccines. 2003 Feb;2(1):129-46. Review.

PMID:
12901604
42.

Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens.

Moore T, Ekworomadu CO, Eko FO, MacMillan L, Ramey K, Ananaba GA, Patrickson JW, Nagappan PR, Lyn D, Black CM, Igietseme JU.

J Infect Dis. 2003 Aug 15;188(4):617-24. Epub 2003 Jul 29.

PMID:
12898452
43.

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.

Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU.

Vaccine. 2003 Apr 2;21(15):1694-703.

PMID:
12639492
44.

Does leptin mediate the effect of photoperiod on immune function in mice?

Bhat GK, Hamm ML, Igietseme JU, Mann DR.

Biol Reprod. 2003 Jul;69(1):30-6. Epub 2003 Feb 5.

PMID:
12606383
45.

Chlamydia vaccines: strategies and status.

Igietseme JU, Black CM, Caldwell HD.

BioDrugs. 2002;16(1):19-35. Review.

PMID:
11908999
46.

Fc receptor regulation of protective immunity against Chlamydia trachomatis.

Moore T, Ananaba GA, Bolier J, Bowers S, Belay T, Eko FO, Igietseme JU.

Immunology. 2002 Feb;105(2):213-21.

47.

Chemokine and chemokine receptor dynamics during genital chlamydial infection.

Belay T, Eko FO, Ananaba GA, Bowers S, Moore T, Lyn D, Igietseme JU.

Infect Immun. 2002 Feb;70(2):844-50.

48.

Sequence analysis of HIV-1 insertion sites in peripheral blood lymphocytes.

Lyn D, Bennett NA, Shiramizu BT, Herndier BG, Igietseme JU.

Cell Mol Biol (Noisy-le-grand). 2001 Sep;47(6):981-6.

PMID:
11785664
49.

Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae.

Igietseme JU, Portis JL, Perry LL.

Infect Immun. 2001 Mar;69(3):1832-40.

50.

Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development.

Igietseme JU, Ananaba GA, Bolier J, Bowers S, Moore T, Belay T, Eko FO, Lyn D, Black CM.

J Immunol. 2000 Apr 15;164(8):4212-9.

Supplemental Content

Loading ...
Support Center